Litcius/Paper detail

Tisotumab Vedotin: First Approval

Anthony Markham

2021Drugs129 citationsDOI

Topics & Concepts

MedicineBrentuximab vedotinAntibody-drug conjugateOncologyInternal medicineClinical trialMonoclonal antibodyChemotherapyPharmacologyAntibodyImmunologyLymphomaHodgkin lymphomaHER2/EGFR in Cancer ResearchMonoclonal and Polyclonal Antibodies ResearchCAR-T cell therapy research
Tisotumab Vedotin: First Approval | Litcius